Autolus Therapeutics plc ADR (NASDAQ: AUTL) kicked off on Friday, down -6.03% from the previous trading day, before settling in for the closing price of $1.99. Over the past 52 weeks, AUTL has traded in a range of $1.11-$2.80.
A company in the Healthcare sector has jumped its sales by 21.35% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -12.14%. With a float of $240.34 million, this company’s outstanding shares have now reached $266.14 million.
Autolus Therapeutics plc ADR (AUTL) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Autolus Therapeutics plc ADR is 9.70%, while institutional ownership is 50.73%.
Autolus Therapeutics plc ADR (AUTL) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.09 earnings per share (EPS), higher than consensus estimate (set at -0.24) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -12.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.49% during the next five years compared to 21.35% growth over the previous five years of trading.
Autolus Therapeutics plc ADR (NASDAQ: AUTL) Trading Performance Indicators
Take a look at Autolus Therapeutics plc ADR’s (AUTL) current performance indicators. Last quarter, stock had a quick ratio of 5.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.84, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.72 in one year’s time.
Technical Analysis of Autolus Therapeutics plc ADR (AUTL)
As of the previous 9 days, the stock’s Stochastic %D was 79.84%.
During the past 100 days, Autolus Therapeutics plc ADR’s (AUTL) raw stochastic average was set at 51.54%, which indicates a significant decrease from 64.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1093 in the past 14 days, which was higher than the 0.1090 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5092, while its 200-day Moving Average is $1.7144. However, in the short run, Autolus Therapeutics plc ADR’s stock first resistance to watch stands at $1.9833. Second resistance stands at $2.0967. The third major resistance level sits at $2.1533. If the price goes on to break the first support level at $1.8133, it is likely to go to the next support level at $1.7567. Assuming the price breaks the second support level, the third support level stands at $1.6433.
Autolus Therapeutics plc ADR (NASDAQ: AUTL) Key Stats
The company with the Market Capitalisation of 497.68 million has total of 266,143K Shares Outstanding. Its annual sales at the moment are 10,120 K in contrast with the sum of -220,660 K annual income. Company’s last quarter sales were recorded 21,190 K and last quarter income was -79,120 K.
